Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al.
Bertoli
Ana M
AM
Font
Yvonne M
YM
Nadal
Anaida
A
Vilá
Luis M
LM
D000210:Acute-Phase Reaction; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D013700:Giant Cell Arteritis / Q000097:blood / Q000188:drug therapy*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D012074:Remission Induction
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D002097:C-Reactive Protein; D011241:Prednisone; D008775:Methylprednisolone